SCHEMBL2106972

SCHEMBL2106972

CC(C)(C)OC(=O)NC(Cc1ccc(F)cc1)C(=O)N1CCC(O)C1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PABPC1 P11940 1/20 0.59
KMT2A Q03164 2/20 0.54
CTSS P25774 1/20 0.53
CTSK P43235 1/20 0.53
POLB P06746 1/20 0.53
MAPK1 P28482 1/20 0.51
P2RX7 Q99572 1/20 0.48
SCN9A Q15858 3/20 0.48
CYP51A1 Q16850 2/20 0.48
PYGL P06737 1/20 0.48
PYGM P11217 1/20 0.48
HRH2 P25021 1/20 0.46
HRH1 P35367 1/20 0.46
ALDH1A1 P00352 1/20 0.46
LMNA P02545 1/20 0.46
DPP4 P27487 1/20 0.45
MC4R P32245 1/20 0.44
MC5R P33032 1/20 0.44
MC3R P41968 1/20 0.44
MC1R Q01726 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2106973 1.00 PABPC1 (0.59) PABPC1KMT2ACTSSCTSKPOLB
SCHEMBL28760270 1.00 PABPC1 (0.59) PABPC1KMT2ACTSSCTSKPOLB
SCHEMBL2107050 0.94 PABPC1 (0.63) PABPC1KMT2ACTSSCTSKPOLB
SCHEMBL2107052 0.94 PABPC1 (0.63) PABPC1KMT2ACTSSCTSKPOLB
SCHEMBL2107346 0.94 PABPC1 (0.63) PABPC1KMT2ACTSSCTSKPOLB
SCHEMBL6165550 0.90 KMT2A (0.66) PABPC1KMT2ACTSSCTSKMAPK1
SCHEMBL6165554 0.90 KMT2A (0.66) PABPC1KMT2ACTSSCTSKMAPK1
SCHEMBL6165558 0.90 KMT2A (0.66) PABPC1KMT2ACTSSCTSKMAPK1
SCHEMBL31278578 0.89 ALDH1A1 (0.58) PABPC1KMT2AMAPK1CYP51A1HRH2
SCHEMBL13747416 0.85 CTSS (0.59) PABPC1KMT2ACTSSCTSKPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8158622-B2 Pyrrolopyridine-2-carboxylic acid amide inhibitors of glycogen phosphorylase PROSIDION LIMITED (GB) 2012-04-17 US disclosed
EP-1636224-B1 PYRROLOPYRIDINE-2-CARBOXYLIC ACID AMIDE INHIBITORS OF GLYCOGEN PHOSHORYLASE PROSIDION LTD (GB) 2010-07-14 EP disclosed
US-20090023703-A1 Pyrrolopyridine-2-carboxylic acid amide inhibitors of glycogen phosphorylase PROSIDION LIMITED (GB) 2009-01-22 US disclosed
US-7405210-B2 Pyrrolopyridine-2-carboxylic acid amide inhibitors of glycogen phosphorylase OSI PHARMACEUTICALS, INC. (US) 2008-07-29 US disclosed
US-20070244090-A9 PYRROLOPYRIDINE-2-CARBOXYLIC ACID AMIDE INHIBITORS OF GLYCOGEN PHOSPHORYLASE BRADLEY STUART E 2007-10-18 US disclosed
US-20050261272-A1 Pyrrolopyridine-2-carboxylic acid amide inhibitors of glycogen phosphorylase PROSIDION LIMITED (GB) 2005-11-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070244090-A9 PYRROLOPYRIDINE-2-CARBOXYLIC ACID AMIDE INHIBITORS OF GLYCOGEN PHOSPHORYLASE PYGL, PYGM, PYGB PABPC1 1305/4885KMT2A 2476/4885CTSS 2832/4885
US-20090023703-A1 Pyrrolopyridine-2-carboxylic acid amide inhibitors of glycogen phosphorylase PYGL, PYGM, PYGB PABPC1 1305/4885KMT2A 2476/4885CTSS 2832/4885
US-20050261272-A1 Pyrrolopyridine-2-carboxylic acid amide inhibitors of glycogen phosphorylase PYGL, PYGM, PYGB PABPC1 1305/4885KMT2A 2476/4885CTSS 2832/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.